We are studying entailung rapid DNA analysis, followed by the rapid synthesis of drugs that can bind, or disable, segments of DNA crucial to an infectious organism's survival.

We are investigating those completed genome sequences for numerous infectious agents, including the bacteria that cause malaria, stomach ulcers and food poisoning, as well as organisms responsible for hospital-acquired infections, cholera, pneumonia and chlamydia. Recently, the genome sequence was completed for a potential biowarfare agent, the organism responsible for bubonic plague (Yersinia pestis).
 

		Therapeutics
		Antivirals, especially against smallpox and viral hemorrhagic fevers.
		Antitoxins to B. anthracis and C. botulinum.
		Narrow-spectrum antibiotics, especially for anthrax.
		Passive immunotherapeutics, including antibodies and soluble receptors.
		Broadly reactive antimicrobials.